Executive Committee

EQS-News: GRAMMER increases revenue and earnings in FY 2023 and appoints COO Guoqiang Li to the Executive Board

Retrieved on: 
Wednesday, April 10, 2024
Commercial vehicle, Tax, Consolidated, Supervisory board, Original equipment manufacturer, CFO, COVID-19, Mercedes-Benz GLC, Executive Committee, Bank statement, Plant, Ursensollen, NEV, Automotive industry, Film industry

Consolidated earnings before interest and taxes amounted to EUR 42.0 million in the 2023 financial year, compared to EUR -45.0 million in the previous year.

Key Points: 
  • Consolidated earnings before interest and taxes amounted to EUR 42.0 million in the 2023 financial year, compared to EUR -45.0 million in the previous year.
  • The more stable business performance in APAC and the positive trend in EMEA had a positive impact on earnings.
  • In addition, GRAMMER was able to reach agreements with customers to pass on the high inflation-related cost increases also in 2023 financial year.
  • Effective April 1, 2024, Guoqiang Li, Chief Operating Officer (COO), will be appointed to the company’s Executive Board.

EQS-News: Bayer and Aignostics to collaborate on next generation precision oncology

Retrieved on: 
Wednesday, April 10, 2024
Algorithm, Disease, Drug discovery, Intelligence, Partnership, Patient, Hospital, Artificial intelligence, Cancer, Executive Committee, AI, Biology, Bayer, Pathology, Machine learning, Pharmaceutical industry

Aignostics is a spin-off from one of the world’s leading hospitals, Charité-Universitätsmedizin Berlin, and a global leader in using computational pathology to transform complex biomedical data into biology insights.

Key Points: 
  • Aignostics is a spin-off from one of the world’s leading hospitals, Charité-Universitätsmedizin Berlin, and a global leader in using computational pathology to transform complex biomedical data into biology insights.
  • The partners will co-create a novel target identification platform that leverages Aignostics’ technology and proprietary multimodal patient cohorts, and Bayer’s deep expertise in discovering and developing novel oncology therapies.
  • Together with Bayer, we’re excited to transform AI’s immense potential into a reality for healthcare,” said Viktor Matyas, CEO of Aignostics GmbH.
  • Aignostics will receive an upfront payment and is eligible to receive success-based milestone payments and royalties on any commercialized therapies that result from the collaboration.

Noah Holdings Becomes the First Non-Bank Chinese Institution to Join PWMA

Retrieved on: 
Wednesday, March 13, 2024
Learning, Acceleration, JPMorgan Chase, London Stock Exchange, Wealth, Research, Policy, Executive Committee, Credit Suisse, Family, AFF, Heart, Human, Tutoring

HONG KONG, Mar 13, 2024 - (ACN Newswire) - On March 11, Noah Holdings (Hong Kong) Limited was honored with full membership by the Private Wealth Management Association (PWMA), marking a significant milestone as the first non-bank institution of Chinese origin to join the prestigious group.

Key Points: 
  • HONG KONG, Mar 13, 2024 - (ACN Newswire) - On March 11, Noah Holdings (Hong Kong) Limited was honored with full membership by the Private Wealth Management Association (PWMA), marking a significant milestone as the first non-bank institution of Chinese origin to join the prestigious group.
  • PWMA is an industry association comprised of numerous distinguished wealth management institutions within the Hong Kong region.
  • Over the past decade, PWMA has consistently organized the highly acclaimed PWMA Wealth Management Summit with famous associations, institutions and companies across the world.
  • Going forward, Noah Holdings will maintain a close relationship with the PWMA, actively seeking avenues for industry development.

Belgium’s Ingmar De Vos elected unanimously as President of the Association of Summer Olympic International Federations

Retrieved on: 
Tuesday, April 9, 2024
RSA, FEI, International Olympic Committee, AZE, EEF, Trust, United, International, United Nations, Diversity, Summer, Executive Committee, Gender equality, Vrije Universiteit Brussel, Legal Affairs, Sports governing body, IOC, Pleasure, Master, GBR, Heart, Gender, Senate, WADA, BEL, Real estate

BIRMINGHAM, United Kingdom, April 09, 2024 (GLOBE NEWSWIRE) -- Belgium’s Ingmar De Vos, who has served as the FEI President since 2014, has been elected unanimously as the new President of the Association of Summer Olympic International Federations (ASOIF). The election took place today, 9 April 2024, at the 48th ASOIF General Assembly held in Birmingham (GBR) during the SportAccord World Sport and Business Summit. Ingmar De Vos ran unopposed and was elected by secret ballot for a term of four years. He will take up his new position on 1 January 2025.

Key Points: 
  • BIRMINGHAM, United Kingdom, April 09, 2024 (GLOBE NEWSWIRE) -- Belgium’s Ingmar De Vos, who has served as the FEI President since 2014, has been elected unanimously as the new President of the Association of Summer Olympic International Federations (ASOIF).
  • “I am humbled by today’s result and would like to express my deep gratitude to the Summer Olympic International Federations for their trust,” the newly elected ASOIF President Ingmar De Vos said.
  • “On behalf of the International Olympic Committee, I would like to extend my heartfelt congratulations to Ingmar De Vos on his election as ASOIF President,” IOC President Thomas Bach commented.
  • Since 2016, he has been a member of the Association of Summer Olympic International Federations (ASOIF) Governance Taskforce.

Madison Investments Opens Downtown Milwaukee Office

Retrieved on: 
Tuesday, April 9, 2024
Longevity, Milwaukee River, Heart, Chase Building, Executive Committee, Interior design

MADISON, Wis., April 09, 2024 (GLOBE NEWSWIRE) -- Madison Investment Holdings Inc (“Madison Investments”), an independently-held investment management firm known for its expertise in actively-managed, high-quality portfolios, announced today the opening of its newest office in downtown Milwaukee.

Key Points: 
  • MADISON, Wis., April 09, 2024 (GLOBE NEWSWIRE) -- Madison Investment Holdings Inc (“Madison Investments”), an independently-held investment management firm known for its expertise in actively-managed, high-quality portfolios, announced today the opening of its newest office in downtown Milwaukee.
  • This move represents a significant step in solidifying the firm’s presence in the Milwaukee market and underscores its commitment to better serving its clients.
  • “While Madison remains our home and headquarters, Milwaukee is an important financial hub in Wisconsin,” said Steve Carl, Chair of the Executive Committee at Madison Investments.
  • "Moving into the heart of downtown Milwaukee signals our bullish outlook on the Milwaukee market," noted Steve Carl.

Northrim BanCorp, Inc. Promotes Huston to President and CEO; Schierhorn Remains Chairman

Retrieved on: 
Friday, March 29, 2024
Culture, Organization, Arizona State University, Growth, First Interstate Bank, Bank, Public–private partnership, University, Executive Committee, Pacific coast, Economic development, Management

ANCHORAGE, Alaska, March 29, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Northrim BanCorp Inc., the parent company of Northrim Bank (NASDAQ: NRIM), named Mike Huston as President and CEO of Northrim BanCorp, effective April 6, 2024.

Key Points: 
  • ANCHORAGE, Alaska, March 29, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Northrim BanCorp Inc., the parent company of Northrim Bank (NASDAQ: NRIM), named Mike Huston as President and CEO of Northrim BanCorp, effective April 6, 2024.
  • Mr. Huston will also serve as Northrim BanCorp’s Chief Operating Officer and Northrim Bank’s President and CEO.
  • “We continue to implement our strategic plan for executive leadership succession and Mr. Huston is a key component of that plan,” said Schierhorn.
  • Huston came to Northrim with over 25 years of experience that include time as Executive Vice President and Chief Banking Officer at First Interstate Bank in Billings, Montana.

Transgene appoints Lucie Larguier as Chief Financial Officer and Christelle Schwoerer as Chief Human Resources Officer

Retrieved on: 
Wednesday, March 27, 2024
Communication, Culture, CNAM, Corporate communication, CFO, École, Knowledge, Sciences Po, Political science, Executive Committee, Cancer, MD, Euronext Paris, Management

Lucie contributed significantly to the smooth execution of four successful securities transactions, as well as to strengthening the external visibility of Transgene.

Key Points: 
  • Lucie contributed significantly to the smooth execution of four successful securities transactions, as well as to strengthening the external visibility of Transgene.
  • Alongside this new appointment, Transgene has promoted Christelle Schwoerer to Chief Human Resources Officer, effective from April 1, 2024, and she also joins the Executive Committee.
  • Christelle Schwoerer joined Transgene’s Human Resources department in 2013, and her knowledge of the organization, its culture and its employees are real assets in her new, expanded role.
  • Christelle Schwoerer holds a Master 1 in human resources from the CNAM Grand-Est and a Master 2 in management and human resources from the Ecole de Management de Strasbourg, which she obtained in 2020 and 2021, respectively.

Attovia Enhances Clinical and Development Expertise with Appointment of Chief Medical Officer and Clinical and Scientific Advisory Boards

Retrieved on: 
Tuesday, March 26, 2024
Tao, Internal medicine, Professor, Patient, Pulmonology, Executive Committee, Drug, Therapy, Chairperson, Sensation, Genentech, NSW, St George's Hospital, Harvard University, MTR, Pediatrics, Stanford University, Teaching hospital, Critical care, Outline of health sciences, KCP, Neuroinflammation, UCSF, Research, Acquisition, University, Management, MPH, Drug development, Atopic dermatitis, Entrepreneurship, Critical Care Medicine (journal), Adolescence, Contact dermatitis, Science, Division, KRYS, Pharmaceutical industry

FREMONT, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- Attovia Therapeutics today announced the appointment of Hubert Chen, M.D., MPH, as Chief Medical Officer, effective March 21, 2024. Dr. Chen brings extensive clinical and industry leadership experience in drug development and joins Attovia from Krystal Biotech (NASDAQ: KRYS), where he was Senior Vice President of Clinical Development. At Attovia, Dr. Chen will lead the company’s clinical development and regulatory functions and will serve on the Executive Committee.

Key Points: 
  • Dr. Chen brings extensive clinical and industry leadership experience in drug development and joins Attovia from Krystal Biotech (NASDAQ: KRYS), where he was Senior Vice President of Clinical Development.
  • At Attovia, Dr. Chen will lead the company’s clinical development and regulatory functions and will serve on the Executive Committee.
  • Prior to Krystal, Dr. Chen was at Genentech/Roche where he held clinical leadership positions across both early and late-stage development.
  • To support the ongoing strategic development of the Attobody platform and advancement of the Company’s emerging pipeline candidates, Attovia has established Clinical and Scientific Advisory Boards comprised of biopharmaceutical industry veterans and academic experts.

Rio Tinto appoints Bold Baatar as Chief Commercial Officer

Retrieved on: 
Sunday, April 7, 2024
Mining, Minerals, Natural Resources, Copper, Growth, Simandou, Partnership, Tinto, Executive Committee, Commercial, Mineral, Energy, Safety, Retirement, Emphasis (typography), Marketing, Iron ore

Rio Tinto has appointed Bold Baatar to the role of Chief Commercial Officer, to lead the Group’s commercial and business development activities globally.

Key Points: 
  • Rio Tinto has appointed Bold Baatar to the role of Chief Commercial Officer, to lead the Group’s commercial and business development activities globally.
  • Bold will succeed Alf Barrios as Chief Commercial Officer, following his decision to retire from Rio Tinto.
  • Bold, who is currently Chief Executive Copper, will take on accountability for business development immediately, and will relocate to Singapore to take up the role of Chief Commercial Officer on 1 September 2024.
  • Rio Tinto Chief Executive Jakob Stausholm said: "Bold is ideally suited to help deliver our strategy of building a stronger Rio Tinto for the future and growing with discipline, as he leads our commercial and business development activities.

Alcon Publishes Agenda for 2024 Annual General Meeting

Retrieved on: 
Sunday, April 7, 2024
Optical, Health, Surgery, Medical Devices, AGM, Executive Committee, Bank statement, Commerce, Annual general meeting, CHF, Hearing, Report

Alcon (SIX/NYSE: ALC), the global leader in eye care, will hold its Annual General Meeting (AGM) on May 8, 2024.

Key Points: 
  • Alcon (SIX/NYSE: ALC), the global leader in eye care, will hold its Annual General Meeting (AGM) on May 8, 2024.
  • The company looks forward to hearing directly from its shareholders at this open format meeting.
  • The agenda for this 2024 AGM consists of the regular items, as well as, newly, the vote on the 2023 Report on Non-Financial Matters.
  • Approval of the operating and financial review of Alcon Inc., the annual financial statements of Alcon Inc. and the consolidated financial statements for 2023
    3.